← Evidence map

TrialBritish journal of haematology2019

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia.

Ibrahim Aldoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31441045